Tag:
Open source R&D
Latest Headlines
Latest Headlines
Gamers illustrate potential of new crowd-sourcing protein work
One of the most intriguing new developments in the drug discovery field has been the recruitment of gamers into the puzzling business of protein folding. Now an initial foray into simple puzzle
Novo crafts fast-track R&D model for new diabetes drug unit
Novo Nordisk ( $NVO ) is setting up a new R&D center in Seattle that aims at reengineering the model for early-stage drug work and speeding up development in the diabetes field. Under the direction
R&D execs continue the global search for efficiency, open innovation
Throughout 2011 we've seen a continuation of an intense reengineering of the development process at a slate of Big Pharma companies. Pfizer ( $PFE ), of course, grabbed the biggest headlines as it
Sanford-Burnham joins Pfizer's growing list of translational med partners
Sanford-Burnham Medical Research Institute in La Jolla, CA has joined the growing list of scientific groups to team up with Pfizer on its new effort to spur translational medicine programs for
Lilly uses web system to find a few diamonds in the rough
Open source, collaborative discovery models are all the rage these days. Researchers interested in vetting their compound's potential while looking for the opportunity to hook up with a pharma giant
Bayer will cap R&D budget at $4.1B
With R&D expenses expected to surge 13 percent this year at Bayer, Germany's largest drug company, CEO Marijn Dekkers is telling reporters that he plans to make sure the budget item flatlines at
Top biologists join Sage's open-source discovery project
Sage Bionetworks has made a big breakthrough in its quest to shatter the multitude of barriers that keep groundbreaking discovery work under tight wraps. Four top biologists have agreed to pool "raw
